Drug Discount Agreements for Interferon beta-1a, Subcutaneous Injection (ATC L03AB07)

Drug discount agreements for the active ingredient Interferon beta-1a, subcutaneous injection (ATC L03AB07): Open-House model for pharmaceutical companies without selection. Maximum contract duration 24 months, earliest contract start 01.10.2026; contracts end no later than 24 months after the earliest contract start. Access possible monthly on the first day, right of termination 6 weeks to month-end. AOK Rheinland-Pfalz/Saarland reserves the right to replace Open-House contracts with exclusive discount agreements from European tenders, which automatically terminate the Open-House contracts. Submission of documents preferably electronically with a qualified electronic signature via email to am_vertraege@rps.aok.de; alternatively, manually signed in 2 written copies (scan via email in advance) to AOK Rheinland-Pfalz/Saarland, Strategisches Vertragsmanagement Arzneimittel, Virchowstraße 30, 67304 Eisenberg. Access to contract information and documents after registration and activation in the project room on www.dtvp.de. Exclusively pharmaceutical companies as contracting partners. Submission deadline for contract start 01.10.2026 is 31.08.2026. Later contract conclusions possible monthly on the first day, submission of documents by the end of the month preceding the desired contract start month.

Tender documents

Additional details